disorders of cardiac function

137
Disorders of Cardiac Function 1

Upload: zada

Post on 11-Jan-2016

72 views

Category:

Documents


12 download

DESCRIPTION

Disorders of Cardiac Function. Introduction. The Heart as Two Pumps. The Heart as Two Pumps. The heart is really two pumps in tandem The right heart sends blood to the lungs The left heart gets blood back from the lungs and sends the blood to the systemic circulation - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Disorders of Cardiac Function

Disorders of Cardiac Function

1

Page 2: Disorders of Cardiac Function

Introduction

2

Page 3: Disorders of Cardiac Function

The Heart as Two Pumps

3

Page 4: Disorders of Cardiac Function

The Heart as Two Pumps

• The heart is really two pumps in tandem– The right heart sends blood to the lungs– The left heart gets blood back from the lungs and

sends the blood to the systemic circulation• This is a bigger job because the systemic circulation is

larger and has more gravity

4

Page 5: Disorders of Cardiac Function

5

Page 6: Disorders of Cardiac Function

Global Tissue Oxygenation

6

Page 7: Disorders of Cardiac Function

Global Tissue OxygenationMade Ridiculously Simple

7

SvO2 = 75%

25%

Venous Oxygen Delivery

ArterialOxygenDelivery

Oxygen Consumption

100%

Page 8: Disorders of Cardiac Function

Global Tissue OxygenationSimple Description

8

Page 9: Disorders of Cardiac Function

Global Tissue OxygenationSimple Description

• Each Hb molecule can carry four oxygen molecules•The hemoglobin in the blood picks up oxygen in the lungs•The hemoglobin sends the oxygen in the blood through the arteries to the tissues•The tissues do not extract 100% of the oxygen from the hemoglobin

–25% of oxygen is in the tissues, 75% in the veins•The Hb then goes back to the loading station

9

Page 10: Disorders of Cardiac Function

Global Tissue OxygenationDetailed Description

10

Page 11: Disorders of Cardiac Function

Global Tissue OxygenationDetailed Description

• The lungs load each hemoglobin with 4 oxygen molecules. • Oxygen content is 20% of total volume. • At the tissue level, Oxygen extraction is a ratio of oxygen consumed

(VO2 = 250 mL/min) to the amount delivered (DO2) = 25%– Thus 75% of oxygen delivered is returned to the venous side, i.e.

normal SvO2 = 75%.• Oxygen consumption (VO2) is a function of cardiac output and the

difference between arterial (Hb x SaO2 x 13.4) and venous oxygen content (Hb x SvO2 x 13.4). – Given the same CO and Hb, VO2 is analogous to the difference

between arterial and venous oxygenation. – For example, 1 Hb will deliver 4 oxygen molecules to the tissue -> 1

oxygen molecule is consumed (VO2) by the tissue + 3 oxygen molecules are returned to the venous outflow.

11

Page 12: Disorders of Cardiac Function

Coronary CirculationDescription

12

Page 13: Disorders of Cardiac Function

Coronary CirculationDescription

• The arteries and veins in the heart perfuse the heart with oxygen

• The coronary arteries come off of the aorta at the place of the aortic valve

• Left and right coronary arteries– Left almost immediately branches into the circumflex and the left

anterior descending artery» Nurses the left side of the heart

– Right – Both nourish the septum

– Blood then goes into the capillaries and then the veins of the heart

– Large vein that delivers the blood back to the heart is the coronary sinus

13

Page 14: Disorders of Cardiac Function

Coronary Coronary CirculationCirculation

14

Page 15: Disorders of Cardiac Function

Cardiac Conduction System

15

Page 16: Disorders of Cardiac Function

Cardiac Conduction System

• Conduction system stimulates the myocardium to contract and pump blood

• Conduction system usually controls the rhythm of the heart (unless the person has a pacemaker)

• Heart has two conduction systems– One controls atrial activity – One that controls ventricular activity

16

Page 17: Disorders of Cardiac Function

Anatomy of the Conduction System

17

Page 18: Disorders of Cardiac Function

Anatomy of the Conduction System

18

SA NodeSA Node

AV NodeAV Node

Bundle of HisBundle of His

Bundle branchesBundle branches

Purkinje fibersPurkinje fibers

Porth, 2007, Essentials of Pathophysiology, 2nd ed., Lippincott, p. 331.

Page 19: Disorders of Cardiac Function

SA Node

19

Page 20: Disorders of Cardiac Function

SA Node• Pacemaker of the heart• Impulses originate

here• Located in posterior

wall RA• Fires at 60 -100 bpm• Responsible for the

heart rate in the normal person

• Impulse causes atrial contraction

20

Page 21: Disorders of Cardiac Function

AV Node

21

Page 22: Disorders of Cardiac Function

AV Node• Connects the atria and

ventricles, provides one way conduction– Would beat

independently• Fires at 40 -60 bpm• Can assume

pacemaker function if SA fails to discharge

• There is a pause here• The speed of

conduction in the AV node is influenced by the SNS (beta-1)

22

Page 23: Disorders of Cardiac Function

Purkinjie Fibers

23

Page 24: Disorders of Cardiac Function

Purkinjie Fibers• Supplies the ventricles• Supplies the impulse to the

cardiac muscle• Large fibers, rapid conduction

for swift and efficient ejection of blood from heart– Large fibers – fast conduction– Small fibers – slow conduction

• Fire 15-40 bpm– Only occurs if there is no input

from the other areas• Assume pacemaker of

ventricles if AV fails• HR reflects intrinsic firing of

these structures

24

Page 25: Disorders of Cardiac Function

Action Potentials (AP)

25

Page 26: Disorders of Cardiac Function

Action Potentials (AP)• Stimulus

– The only intrinsic conduction in the heart is in the SA node

• Any other conduction comes from depolarization of the muscle

excitable tissues (muscle and conduction system) evokes an AP characterized by a sudden change in

voltage resulting from transient depolarization and then repolarization.

• AP’s are electrical currents involving the movement/flow of electrically charged ions at level of cell membrane.

• AP’s are conducted throughout the heart, responsible for initiating each cardiac contraction.

26

Page 27: Disorders of Cardiac Function

27

Page 28: Disorders of Cardiac Function

Types of Action Potentials

28

Page 29: Disorders of Cardiac Function

SLOW SA & AV Nodes

FAST

Purkinje Fiber & Muscle

29

Page 30: Disorders of Cardiac Function

Types of Membrane Ion Channels that Contribute to

Voltage Changes during the AP

30

Page 31: Disorders of Cardiac Function

Types of Membrane Ion Channels that Contribute to Voltage Changes

during the AP

1. Fast Na+ channels• Rapid depolarization of muscles• Important in cardiac APs and Purkinje

fibers2. Slow Na+ channels

• Pacemaker activity (SA, AV)3. Potassium channels

• Speedy repolarization31

Page 32: Disorders of Cardiac Function

Three Phases of Action Potentials

32

Page 33: Disorders of Cardiac Function

Three Phases of Action Potentials

• Resting

• Depolarization

• Repolarization

33

Page 34: Disorders of Cardiac Function

Resting Phase

34

Page 35: Disorders of Cardiac Function

Resting Phase

• Membrane is relatively permeable to K+, but much less so to Na+

• Inside is negative, outside is positive

35

Page 36: Disorders of Cardiac Function

Cardiac Muscle Cell Firing

• Cells begin with a negative charge: resting membrane potential

• Calcium leak lets Ca2+ diffuse in, making the cell more positive

36

Threshold potential

Resting membrane potential Calcium

leak

Page 37: Disorders of Cardiac Function

Depolarization Phase

37

Page 38: Disorders of Cardiac Function

Depolarization Phase

• Cell membrane becomes permeable to Na+

• Na+ enters cell, inside the cell is more +

38

Page 39: Disorders of Cardiac Function

Cardiac Muscle Cell Firing (cont.)• At threshold

potential, more Na+ channels open

• Na+ rushes in, making the cell very positive: depolarization

• Action potential: the cell responds (e.g. by contracting)

39

Threshold potential

Resting membrane potential

Action potential

Calcium leak

Page 40: Disorders of Cardiac Function

Plateau Phase

40

Page 41: Disorders of Cardiac Function

Cardiac Muscle Cell Firing (cont.)

• K+ channels open• K+ diffuses out,

making the cell negative again (starting to repolarize), but Ca2+ channels are still allowing Ca2+ to enter

• The cell remains positive: plateau

41

Threshold potential

PLATEAU

Action potential

Calcium leak

Page 42: Disorders of Cardiac Function

Repolarization Phase

42

Page 43: Disorders of Cardiac Function

Repolarization Phase

• Outward flow of positive charges, mainly K+

• Inside the cell is more negative

• Assisted by Na+-K+ pump– Relatively slow method of repolarization

• Potassium ions made a bigger, faster difference

43

Page 44: Disorders of Cardiac Function

Cardiac Muscle Cell Firing (cont.)• During plateau,

the muscle contracts strongly

• Then the Ca2+ channels shut and it repolarizes

– The potassium channels opened a while ago so the potassium comes out, leading to repolarization

44

Threshold potential

PLATEAUAction potential

Calcium leak

Page 45: Disorders of Cardiac Function

Cardiac Action Potentials

45

Page 46: Disorders of Cardiac Function

Cardiac Action Potentials• Unlike nerve cells, cardiac cells have five phases in their action

potential– Phase 4 – the resting membrane potential.

– Phase 0 – there is rapid depolarization• The QRS complex corresponds to this section

– Phase 1 – there is a short repolarization (only observed in ventricular muscle)

• Occurs right in the end of depolarization• Only observed in ventricular muscle

– Phase 2 – the membrane potential remains depolarized in a plateau

• When calcium is entering the cell, so further repolarization is prevented (because cell is more positive)

– Phase 3 – the membrane potential becomes repolarized.• The T wave corresponds to the repolarization 46

Page 47: Disorders of Cardiac Function

Cardiac Muscle Action PotentialCardiac Muscle Action Potential 5 Phases5 Phases

Phase 0: Upstroke, rapid depolarization

Phase 1: Early, short repolarization

Seen only in ventricular musclePhase 2:

Plateau phase; membrane potential remains depolarized

Phase 3: Final rapid repolarization

Phase 4: Resting, diastolic repolarization

Unlike nerve cells, cardiac cells Unlike nerve cells, cardiac cells have 5 phases in their action have 5 phases in their action

potential.potential.

47

Page 48: Disorders of Cardiac Function

Cardiac Muscle Cell Contraction

48

Page 49: Disorders of Cardiac Function

Cardiac Muscle Cell Contraction• During Phase 2, the plateau, calcium ion enters the

muscle cell, causing it to contract strongly.

• The strength of contraction is directly proportional to the number of calcium ions that enter the cell.

• Calcium channel opening is controlled by voltage (the calcium channels only open when the membrane is at a certain voltage) and by beta1 receptors in the ventricular myocardium.

49

Page 50: Disorders of Cardiac Function

Importance of Actions Potentials

50

Page 51: Disorders of Cardiac Function

Lehne 5th ed Figure 47-2

Myocardium& His-Purkinje

System

SA Node &AV Node

Why are action potentials important?

• Source of dysrhythmias

• Targets of drug action

51

Page 52: Disorders of Cardiac Function

Cardiac Conduction andRhythm Disorders

52

Page 53: Disorders of Cardiac Function

ECGRelationship to Action Potential

53

Page 54: Disorders of Cardiac Function

ECGRelationship to Action Potential

• Electrical events recorded on ECG

• Electrical events precede mechanical events; know what they represent!– P

• Represents the depolarization of the atria• Then there is a delay from the AV node

– QRS• Depolarization of the ventricle

– T• Repolarization of the ventricle

– U wave• Repolarization of the atria (at times may be masked by the QRS

complex)

54

Page 55: Disorders of Cardiac Function

55

Page 56: Disorders of Cardiac Function

Electrical and Mechanical EventsDiagram

56

Page 57: Disorders of Cardiac Function

57Lehne 5th ed Figure 47-3

Electrical event precedes mechanical event !!!

Page 58: Disorders of Cardiac Function

Location of Electrical Events in the Heart

58

Page 59: Disorders of Cardiac Function

Porth 2007, Figure 16-12

P waveAtria

PR IntervalAV node

QRS complexventricles

T wave: Repolarization of the ventricles

59

Page 60: Disorders of Cardiac Function

Disorders of Cardiac Rhythm and Conduction

60

Page 61: Disorders of Cardiac Function

Disorders of Cardiac Rhythm and Conduction

1. Dysrhythmias (or arrhythmias)

– Term used to describe disorders of cardiac rhythm

– Occur in healthy and non-healthy people– Interfere with heart’s pumping ability

2. Disorders of impulse conduction– Impulses that originated in the SA node do not

get through or the SA node does not work well

61

Page 62: Disorders of Cardiac Function

Causes of Dysrhythmias

62

Page 63: Disorders of Cardiac Function

Causes of Dysrhythmias• Congenital defects in conduction system• Degenerative changes

– As we get old, things do not work as well as it used to• Ischemia and MI

– May lead to degenerative changes– May be due to narrowing of the coronary arteries or a

clot• Fluid/electrolyte imbalances

– If the ions are not present in the proper concentration, it influences how they can rush into and out of the cell

• Drugs

63

Page 64: Disorders of Cardiac Function

Sinus Node Rhythms

64

Page 65: Disorders of Cardiac Function

Sinus Node Rhythms

• Normal Sinus Rhythm

• Sinus Bradycardia

• Sinus Tachycardia

65

Page 66: Disorders of Cardiac Function

Normal Sinus Rhythm

66

Page 67: Disorders of Cardiac Function

Normal Sinus Rhythm

• P wave precedes each QRS

• RR intervals (between each QRS complex) are regular

• Rate 60-100

• May vary slightly with breathing due to changing pressures within the heart chambers

67

Page 68: Disorders of Cardiac Function

Sinus Bradycardia

68

Page 69: Disorders of Cardiac Function

Sinus Bradycardia

• P before QRS

• RR regular

• Rate < 60– Slowing of conduction through AV node seen as

a lengthened PR interval (Vagal, PNS)

69

Page 70: Disorders of Cardiac Function

Sinus Tachycardia

70

Page 71: Disorders of Cardiac Function

Sinus Tachycardia

• P before QRS

• RR regular

• Rate > 100

• Enhanced automaticity r/t SNS activation (fever, exercise, stress)

71

Page 72: Disorders of Cardiac Function

Class II Antidysrhythmics

72

Page 73: Disorders of Cardiac Function

Lehne 5th ed Figure 47-2

Myocardium& His-Purkinje

System

SA Node andAV Node

73

Class II Antidysrhythmic

Page 74: Disorders of Cardiac Function

Class II Antidysrhythmic Beta Blockers

74

Page 75: Disorders of Cardiac Function

Class II Antidysrhythmic Beta Blockers

• Depress Phase 4 in depolarization

• Slow the heart rate– Prolong PR interval and lead to bradycardia (because

of chronotropic effects)

• Nonselective: Carvedilol, Propranolol: – Block beta 1 and beta 2 receptors

• Blockage of beta-2 receptors may worsen asthma by blocking the bronchodilation of the receptors

• Cardioselective: Metolprolol, Esmolol: – Block beta 1 only

75

Page 76: Disorders of Cardiac Function

Class II Antidysrhythmic Mechanism of Action

76

Page 77: Disorders of Cardiac Function

Class II Antidysrhythmic Mechanism of Action

• (-) Inotrope– Refer to contractility of the heart– Beta-1 receptors are in the ventricles and activation

leads to contractility

• (-) Chronotrope – SLOW the heart rate!– Heart rate– SA node

• (-) Dromotrope– The speed of conduction, particularly in the AV node– Beta-1 receptor stimulation speeds up the conduction of

the AV node

77

Page 78: Disorders of Cardiac Function

Class II Antidysrhythmic Therapeutic Uses

78

Page 79: Disorders of Cardiac Function

Class II Antidysrhythmic Therapeutic Uses

• PSVT– Paraxoysomal supra-ventricular tachycardia

• Comes and goes• Above the ventricule (originates in the SA node or the AV node)• Fast heart rate

– Common in young people– Every once in a while, their heart starts racing– May or may not be bothersome or disabling– Beta-blockers prevent the rapid heart rate by slowing conduction in the

AV node• Angina

– The heart does not get enough oxygen– The treatment is to decrease the oxygen demand of the heart

• The beta-blockers do this by slowing heart rate and reducing contractility• AMI

– Beta-blockers prevent second MIs• Hypertension (HTN) (not esmolol)• Heart Failure (HF) (carvedilol, metoprolol)

79

See Lehne Table 18-2 and 18-3

Page 80: Disorders of Cardiac Function

Beta BlockersAdverse Effects

80

Page 81: Disorders of Cardiac Function

Beta BlockersAdverse Effects

• Hypotension– May lead to fainting

• Syncope• Precipitate heart failure

– This is because of their inotropic, chronotropic, and dromotropic factors

• Bradycardia• AV block due to too much of a decrease in the AV node

– The ventricles (Purkinje fibers) take over at their slow speed– The person may faint because the slow speed is not enough to get

oxygen to the body• Sinus arrest

– Problems in the SA node?• Bronchospasm (non-selective beta blockers)• Rebound cardiac excitation (if abruptly stopped)

– Need to taper the dose of the beta-blockers

81

Page 82: Disorders of Cardiac Function

Beta Blocker Administration

82

Page 83: Disorders of Cardiac Function

Beta Blocker Administration

83

Drug Route ½ Life (hrs) Indication

Esmolol IV ONLY! 0.15 Dysrh, angina

Metoprolol IV, PO 3-7 Dysrh, angina, AMI, HF, HTN

Atenolol IV, PO 6-9 Dysrh, angina, AMI

Carvedilol PO 5-11 Angina, AMI, HF, HTN

Propanolol IV, PO 3-5 Dysrh, angina, AMI, HTN

Page 84: Disorders of Cardiac Function

Atrial Dysrhythmias

84

Page 85: Disorders of Cardiac Function

Atrial Dysrhythmias•Atrial Fibrillation: •The impulse arises in the atrium, but not in the SA node•Chaotic and disorganized impulse generation in the atria

•There is no organized contraction of the atria•Atria are depolarizing without contracting (just quivering).

•Occasional ones will be conducted and cause AV contraction•Ventricular rhythm irregular because not all of the contractions are conducted to the AV node

•Only irregularly irregular rhythm.•There is no pattern to it

•No discernable P waves.•Because there is no organized depolarization of the atria

85

Page 86: Disorders of Cardiac Function

A-Fib TreatmentDigoxin

86

Page 87: Disorders of Cardiac Function

A-Fib TreatmentDigoxin

• First want to use an anti-coagulant in order to prevent the formation of a blood clot

• A cardiac glycoside that is used for atrial fibrillation or atrial flutter.

• Slows conduction in the AV node and thereby slows ventricular rate.– Allows fewer of the atrial fibrillations or impulses to get to the

AV node and the ventricles

• Does not treat the dysrhythmia, just slows the heart rate

87

Page 88: Disorders of Cardiac Function

DigoxinMechanism of Action

88

Page 89: Disorders of Cardiac Function

DigoxinMechanism of Action

• Mechanism of Action:– Inhibits Na+-K+ ATPase pump

• More intracellular calcium available inside the cell

• + inotrope– Increases the force of contraction

– Enhance vagal influence (SA and AV node effect)• - chronotrope, - dromotrope • Negative dromotrope helps control the

response of chaotic impulses89

Page 90: Disorders of Cardiac Function

DigoxinTherapeutic Uses

90

Page 91: Disorders of Cardiac Function

DigoxinTherapeutic Uses

• Heart failure

• Atrial flutter/fibrillation

91

Page 92: Disorders of Cardiac Function

DigoxinMechanism of Action

Diagram

92

Page 93: Disorders of Cardiac Function

93

Lehne 6th ed Figure 47-4

Page 94: Disorders of Cardiac Function

DigoxinPharmacokinetics

94

Page 95: Disorders of Cardiac Function

DigoxinPharmacokinetics

Absorption 60 – 80% (tabs)

70 – 85% (elixir)

90 – 100% (caps)

Metabolism Liver

Half Life 5-7 DAYS to eliminate

& T½ 1.5 days

95

Page 96: Disorders of Cardiac Function

DigoxinAdministration Considerations

96

Page 97: Disorders of Cardiac Function

DigoxinAdministration Considerations

• PO or IV (mcg NOT mg)– “Digitalization”

• Can give an IV loading dose

• Digoxin levels (0.5 - 1.1 ng/ml)– VERY narrow therapeutic range– Digoxin immune FAB (antidote) for toxic levels ( > 2.0

ng/ml)• The antibody binds up all of the digoxin in the bloodstream

– D/C drug until toxicity resolves• Toxicity can be fatal

97

Page 98: Disorders of Cardiac Function

DigoxinAdverse Effects

98

Page 99: Disorders of Cardiac Function

DigoxinAdverse Effects

• Digoxin induced dysrhythmias– All types! – Bradycardia– AV block most common– Ventricular flutter/fibrillation is the most dangerous

effect• This is how most people die

• GI : Anorexia, N/V • CNS: Drowsiness/weakness,

– Blurred vision/colored (yellow) halos99

Page 100: Disorders of Cardiac Function

100

Page 101: Disorders of Cardiac Function

DigoxinContraindications

101

Page 102: Disorders of Cardiac Function

DigoxinContraindications

•2nd/3rd degree heart block

•V. Fib/V. Tach

•Sick Sinus Syndrome–When the sinus node quits working

102

Page 103: Disorders of Cardiac Function

Digoxin Precautions

103

Page 104: Disorders of Cardiac Function

Digoxin Precautions

•Acute MI

•Renal insufficiency

•Hypokalemia

•Severe pulmonary disease

104

Page 105: Disorders of Cardiac Function

DigoxinAdditional Considerations

105

Page 106: Disorders of Cardiac Function

DigoxinAdditional Considerations

• Potassium levels Keep in 3.5 – 5.0 mEq/L range

– Digoxin competes with K+ at binding sites• If potassium is low, there may be more binding sites for

toxicity– Hyperkalemia decreases digoxin effect– Diuretics may cause hypokalemia

digoxin toxicity

106

Page 107: Disorders of Cardiac Function

DigoxinDrugDrug Interactions

107

Page 108: Disorders of Cardiac Function

DigoxinDrugDrug Interactions

Reduce digoxin therapeutic effect • ACE-I and ARBs

– Increase potassium

Additive digoxin effect• Sympathomimetics

– work in conjunction with digoxin to increase contractility and HR

– Increase risk of tachydysrhythmias

• Numerous interactions (Lehne Table 47-2)

108

Page 109: Disorders of Cardiac Function

DrugDrug InteractionsIncrease Risk of Digoxin Toxicity

109

Page 110: Disorders of Cardiac Function

DrugDrug InteractionsIncrease Risk of Digoxin Toxicity

• Calcium channel blockers (verapamil)– Increase serum digoxin level– Decrease HR– Bradydysrhythmias or complete heart block

• Diuretics may reduce potassium levels– Increase risk of dig-induced dysrhythmias

• Herbal interactions increase metabolism– It is too complicated with metabolism to use herbal medications

110

Page 111: Disorders of Cardiac Function

DigoxinNursing Implications

111

Page 112: Disorders of Cardiac Function

DigoxinNursing Implications

112

Apical pulse for 1 minute and document

Monitor ECG

Monitor potassium and digoxin levels

Page 113: Disorders of Cardiac Function

A-Fib, PSVT TreatmentClass IV Antidysrhythmic Calcium Channel Blockers

113

Page 114: Disorders of Cardiac Function

A-Fib, PSVT TreatmentClass IV Antidysrhythmic Calcium Channel Blockers

• Verapamil, diltazem– Nondihydropyridines

• Mechanism of Action:– Inhibits calcium influx during depolarization– Depresses phase 4 of depolarization– Prolongs phases 1 and 2 of depolarization

114

Page 115: Disorders of Cardiac Function

Class IV AntidysrhythmicsDiagram

115

Page 116: Disorders of Cardiac Function

Lehne 5th ed Figure 47-2

Myocardiumand His-Purkinje

System

SA Node andAV Node

116

Page 117: Disorders of Cardiac Function

Class IV Antidysrhythmic Effects on the Heart

117

Page 118: Disorders of Cardiac Function

Class IV Antidysrhythmic Effects on the Heart

Three effects on the heart1. Slow SA node automaticity slow HR

2. Delay AV node conduction prolong PR- The pause is greater at the AV node- The PR interval is what is going on in the AV node

3. myocardial contractility CO• Note: same effects as Beta Blockers!!!!!

– Need to be mindful of the effects because they may be increased

– Blood pressures decrease when on calcium channel blockers118

Page 119: Disorders of Cardiac Function

Class IV Antidysrhythmic Therapeutic Uses

119

Page 120: Disorders of Cardiac Function

Class IV Antidysrhythmic Therapeutic Uses

• PSVT• Atrial Fib/Flutter (slow ventricular rate)• Angina

– Angina is caused by ischemia, which is caused by lack of bloodflow to the heart (which means lack of oxygen)

– Calcium channel blocker is used to treat angina because it slows heart rate and decreases contractility, so the myocardium will not use as much oxygen

• It is also helpful because it makes diastole longer, so there is more time to have oxygen perfusion

• Hypertension• Note: not effective for ventricular dysrhythmias !!

– Only affects the SA and AV nodes

120

Page 121: Disorders of Cardiac Function

Verapamil and DiltiazemAdverse Cardiac Effects

121

Page 122: Disorders of Cardiac Function

Verapamil and DiltiazemAdverse Cardiac Effects

• Bradycardia

• AV block

• Decreased myocardial contractility decreased cardiac output

122

Page 123: Disorders of Cardiac Function

Verapamil and DiltiazemAdverse General Effects

123

Page 124: Disorders of Cardiac Function

Verapamil and DiltiazemAdverse General Effects

• Dizziness due to increased vasodilation and less perfusion to the brain

• Facial Flushing• Headache• Peripheral edema• Decreased GI motility

124

Page 125: Disorders of Cardiac Function

Disorders of Atrioventricular Conduction

125

Page 126: Disorders of Cardiac Function

Disorders of Atrioventricular Conduction

• First degree AV block

• Second degree AV block

• Third degree AV block (complete AV block)

126

Page 127: Disorders of Cardiac Function

First Degree AV Block

127

Page 128: Disorders of Cardiac Function

First Degree AV Block

• Slightly prolonged PR interval

• ALL atrial impulses are conducted to ventricles

• Asymptomatic.

• Everything is in the right order

128

Page 129: Disorders of Cardiac Function

Second Degree AV Block

129

Page 130: Disorders of Cardiac Function

Second Degree AV Block

• Not all atrial impulses are conducted to ventricles– See some P waves not followed by QRS.

• Can be very symptomatic.

130

Page 131: Disorders of Cardiac Function

Third Degree (Complete) AV Block

131

Page 132: Disorders of Cardiac Function

Third Degree (Complete) AV Block

• Conduction link between atria and ventricles lost– Each controlled by independent pacemakers

• Atria continue at their rate, ventricles contract at their rate (30-40 bpm)

• The P wave and the QRS wave occur at regular intervals but they do not coincide

132

Page 133: Disorders of Cardiac Function

Case Study: Digoxin Toxicity

133

Page 134: Disorders of Cardiac Function

Case Study: Digoxin ToxicitySerum dig level = 1.7 ng.ml (0.5-1.1 desired)

134

33rdrd degree AV degree AV BlockBlock

Temporary pacemaker inserted, SR Temporary pacemaker inserted, SR 100% 100% pacedpaced

Page 135: Disorders of Cardiac Function

Complete A-V block with 100% atrio-ventricular pacing

135

Atrial Pacingspike

Ventricular Pacingspike

P QRS

Page 136: Disorders of Cardiac Function

Ventricular Dysrhythmias: More Serious!

136

Page 137: Disorders of Cardiac Function

Ventricular Dysrhythmias: More Serious!

• PVC – premature ventricular contraction

• V-fib – ventricular fibrillation

• V-tach – ventricular tachycardia

137